Vemircopan (ALXN2050) monotherapy in paroxysmal nocturnal hemoglobinuria: Interim data from a phase 2 open-label proof-of-concept study

被引：0
|
作者：
Browett, Peter [1 ]
Kulasekararaj, Austin [2 ,3 ]
Notaro, Rosario [4 ,5 ]
Ogawa, Masayo [6 ]
Risitano, Antonio [7 ,8 ]
Yu, Ji [6 ]
Lee, Jong Wook [9 ]
机构：
[1] Univ Auckland, Auckland, New Zealand
[2] Kings Coll Hosp NHS Fdn Trust, NIHR Wellcome Kings Clin Res Facil, London, England
[3] Kings Coll London, London, England
[4] Azienda Osped Univ Careggi, Florence, Italy
[5] Inst Studio Prevenz & Rete Oncol, Florence, Italy
[6] Alexion, AstraZeneca Rare Dis, Boston, MA USA
[7] Federico II Univ Naples, Naples, Italy
[8] AORN Moscati, Avellino, Italy
[9] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Seoul, South Korea
来源：
IMMUNOBIOLOGY | 2023年 / 228卷 / 05期
关键词：
D O I：
10.1016/j.imbio.2023.152638
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
188
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [31] Interim Analysis of Subject Impression Data for STS101 From the Phase 3 Open-Label ASCEND Study
    Ailani, Jessica
    Charleston, Larry
    Albrecht, Detlef
    NEUROLOGY, 2023, 100 (17)
  • [32] A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study
    Misbah, Siraj A.
    Baumann, Andreas
    Fazio, Raffaella
    Dacci, Patrizia
    Schmidt, Dirk S.
    Burton, Janet
    Sturzenegger, Matthias
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 (02) : 92 - 97
  • [33] Interim Analysis of STS101 Nasal Safety Data From the Phase 3 Open-Label ASCEND Migraine Study
    Spierings, Egilius
    Albrecht, Detlef
    Rapoport, Alan
    NEUROLOGY, 2023, 100 (17)
  • [34] Survival Data From a Phase II, Open-Label Study of Pazopanib or Lapatinib Monotherapy in Patients With Advanced and Recurrent Cervical Cancer
    Monk, Bradley J.
    Pandite, Lini N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (36) : 4845 - 4845
  • [35] The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study
    Antongiulio Faggiano
    Roberta Modica
    Rosa Severino
    Luigi Camera
    Rosa Fonti
    Michela Del Prete
    Maria Grazia Chiofalo
    Massimo Aria
    Piero Ferolla
    Giovanni Vitale
    Luciano Pezzullo
    Annamaria Colao
    Endocrine, 2018, 62 : 46 - 56
  • [36] The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study
    Faggiano, Antongiulio
    Modica, Roberta
    Severino, Rosa
    Camera, Luigi
    Fonti, Rosa
    Del Prete, Michela
    Chiofalo, Maria Grazia
    Aria, Massimo
    Ferolla, Piero
    Vitale, Giovanni
    Pezzullo, Luciano
    Colao, Annamaria
    ENDOCRINE, 2018, 62 (01) : 46 - 56
  • [37] Trial in Progress: The Phase III, Randomized, Open-Label, Multicenter COMMODORE 2 Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Adult and Adolescent Patients with Paroxysmal Nocturnal Hemoglobinuria Not Previously Treated with Complement Inhibitors
    Kulasekararaj, Austin
    He, Guangsheng
    Munir, Talha
    Pu, Jeffrey
    Risitano, Antonio
    Roth, Alexander
    Sima, Camelia S.
    Appius, Anita
    Sostelly, Alexandre
    Sreckovic, Sasha
    Vignal, Charlotte
    Nishimura, Jun-Ichi
    BLOOD, 2020, 136
  • [38] Phase 2 Open-Label Extension Study With Donidalorsen in Patients With Hereditary Angioedema: Updated Interim Analysis With Quality-of-Life Data
    Bordone, Laura
    Newman, Kenneth
    Lui, Cindy
    Alexander, Veronica
    Riedl, Marc
    Schneider, Eugene
    Cohn, Danny
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB129 - AB129
  • [39] Interim Results from the NEXUS Open-Label Phase 2 Study on the Safety and Efficacy of Leriglitazone in the Treatment of Childhood Cerebral Adrenoleukodystrophy
    Musolino, P. L.
    Mallack, E.
    Garcia-Cazorla, A.
    Ribeiro, J.
    Sevin, C.
    Yazbeck, E.
    Rosewich, H.
    Jimenez, S.
    Chia-Yi, Chiang G.
    Rapalino, O.
    Caruso, P.
    Helmer, K.
    Balentine, D.
    Pascual, S.
    ANNALS OF NEUROLOGY, 2023, 94 : S33 - S34
  • [40] Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria
    Schrezenmeier, Hubert
    Kulasekararaj, Austin
    Mitchell, Lindsay
    de Latour, Regis Peffault
    Devos, Timothy
    Okamoto, Shinichiro
    Wells, Richard
    Popoff, Evan
    Cheung, Antoinette
    Wang, Alice
    Tomazos, Ioannis
    Patel, Yogesh
    Lee, Jong Wook
    ANNALS OF HEMATOLOGY, 2024, 103 (01) : 5 - 15
12345